List view / Grid view
22 January 2015 | By GlobalData
The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023, representing a high Compound Annual Growth Rate (CAGR) of almost 9.9%, says research and consulting firm GlobalData...
CAMO Software will be exhibiting at the IFPAC® Annual Meeting in Arlington, VA (Washington D.C.) January 25-28. CAMO Software can be found in booth #709...
21 January 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)...
21 January 2015 | By Aurora
A once daily injection has been approved for adults with type 2 diabetes and moderate renal impairment (stage 3 chronic kidney disease) in the UK...
21 January 2015 | By Citigate Dewe Rogerson
Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon® is now open with the US Food & Drug Administration...
21 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders’ Meeting on May 5...
21 January 2015 | By GlobalData
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set to come under increased scrutiny, says an analyst with research and consulting firm GlobalData...
21 January 2015 | By Distributed by APO (African Press Organization) on behalf of Rotary International
Nigeria marks progress, having gone six months without a case of polio...
20 January 2015 | By Edelman
We believe NPS is a solid acquisition and are confident management can extract significant Revenue and operating synergies, with focus on the 24 Jan FDA action on Natpara...
20 January 2015 | By B3C newswire
TAVIguide™ supports transcatheter aortic valve implantation (TAVI)...
19 January 2015 | By Celgene
An oral therapy for moderate-to-severe chronic plaque psoriasis and active psoriatic arthritis, with no drug-specific pre-screening or laboratory monitoring requirements...
19 January 2015 | By The UK Clinical Pharmacy Association and Pharmacy Research UK
The UK Clinical Pharmacy Association (UKCPA) and Pharmacy Research UK are continuing their partnership in 2015 to offer a research fund of up to £50,000 to support pharmacy practitioners to take forward their research within clinical pharmacy...
19 January 2015 | By Novo Nordisk
Novo Nordisk announced Switzerland as the first country to launch Xultophy® (IDegLira) for people with type 2 diabetes...
19 January 2015 | By Alliance Pharma plc
Alliance Pharma plc, the speciality pharmaceutical company, announces its pre-close trading update ahead of its preliminary results for the year ended 31 December 2014...
19 January 2015 | By Roche
Today Roche opened its new Learning Center in Kaiseraugst. Besides offering a superlative infrastructure for trainees, the Learning Center contains a state-of-the-art school laboratory, which in this form is unparalleled in Switzerland...
